Estrogen and progesterone receptor proteins in patients with breast cancer (Q40778803)

23 September 2017

1 reference

title

Estrogen and progesterone receptor proteins in patients with breast cancer (English)

1 reference

23 September 2017

Menendez-Botet CJ

1

1 reference

23 September 2017

Schwartz MK

series ordinal

2

1 reference

23 September 2017

publication date

1 January 1993

1 reference

Advances in Clinical Chemistry

23 September 2017

published in

1 reference

23 September 2017

volume

30

1 reference

23 September 2017

page(s)

185-225

1 reference

Levels of Estrogen and Progesterone Receptor Proteins in Patients with Breast Cancer During Various Phases of the Menses

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

DNA synthesis in estrogen receptor-positive human breast cancer takes place preferentially in estrogen receptor-negative cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Adjuvant chemotherapy in premenopausal patients with primary breast cancer; relation to drug-induced amenorrhoea, age and the progesterone receptor status of the tumour

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

The value of estrogen and progesterone receptor determinations in advanced breast cancer. Estrogen receptor level but not progesterone receptor level correlates with response to tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Relationship of oestrogen-receptor status to survival in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, estrogen receptor-positive breast cancer patients: results of a multicentric Italian study. Breast Cancer Adjuvant Chemo-Hormone Therapy Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Investigation on the thermostability of steroid hormone receptors in lyophilized calf uterine tissue powder.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Effects of molybdate on classification of estrogen and progesterone receptor status in human breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

The effect of thiols on oestradiol binding by components of human malignant breast tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Estrogen receptor protein of breast cancer as a predictor of recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Progesterone receptors and human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Prediction of endocrine response in breast cancer by immunocytochemical detection of oestrogen receptor in fine-needle aspirates

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Stability of oestrogen receptor status in sequential biopsies from patients with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Special report. Steriod receptors in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Endocrine consequences of CMF adjuvant therapy in premenopausal and postmenopausal breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

The predictors of distant relapse following conservative surgery and radiotherapy for early breast cancer are similar to those following mastectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Estrone and estradiol content in human breast tumors: Relationship to estradiol receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Use of monoclonal antiestrogen receptor antibody to evaluate estrogen receptor content in fine needle aspiration breast biopsies.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Studies with tritium-labelled hexoestrol in advanced breast cancer. Comparison of tissue accumulation of hexoestrol with response to bilateral adrenalectomy and oophorectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Sedimentation profiles of the oestrogen receptor from breast tumours of man and rat using vertical-tube rotor centrifugation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Monoclonal antibodies to human estrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Properties of the estrogen receptor in the soluble fraction of human uterus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Oestrogen receptors and breast cancer: current status

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

The cytochemical detection of oestrogen receptors in fine needle aspirates of breast cancer; correlation with biochemical assay and prediction of response to endocrine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

The lack of relationship between estrogen receptor status and response to chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Specific progesterone receptors in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

The effect of post-operative radiotherapy in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Randomized clinical trial of diethylstilbestrol versus tamoxifen in postmenopausal women with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Additive hormonal therapy in women with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Combination hormonal therapy with tamoxifen plus fluoxymesterone versus tamoxifen alone in postmenopausal women with metastatic breast cancer. An updated analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Simultaneous and sequential determinations of steroid hormone receptors in human breast cancer. Influence of intervening therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Estrogen receptor protein in visceral metastases from breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Oestrogen receptor status of primary breast carcinomas and their metastases. Relation to pattern of spread and survival after recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Ring-substituted [1,2-bis(4-hydroxyphenyl)ethylenediamine]dichloroplatinum (II) complexes: compounds with a selective effect on the hormone-dependent mammary carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Effect of snap freezing, dithiothreitol and storage on estimations of estrogen receptor sites

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Fluoxymesterone therapy in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Estrogen receptor status and response to chemotherapy in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Monoclonal antibodies localize oestrogen receptor in the nuclei of target cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Estrogen receptor protein in breast cancer as a predictor of recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Estrogen receptor protein of breast cancer in patients with positive nodes. High recurrence rates in the postmenopausal estrogen receptor-negative group

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Fine-needle aspiration of the breast: diagnoses and pitfalls. A review of 3545 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Specific estrogen binding by the cytoplasm fof human breast carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Risk factors for breast recurrence in premenopausal and postmenopausal patients with ductal cancers treated by conservation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Why are local recurrences after breast-conserving therapy more frequent in younger patients?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Nuclear oestrogen receptors and treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Estrogen and progesterone receptors in breast carcinoma: Correlations with epidemiology and pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Pleural effusion in breast cancer. Thoracoscopy for hormone receptor determination.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

A clinical evaluation of nuclear estrogen receptors combined with cytosolic estrogen and progesterone receptors in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

The problem of nonresponding estrogen receptor-positive patients with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Influence of estrogen receptors on survival and recurrence in patients with breast cancer without lymph node metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Estrogen and progesterone receptors in the prediction of response of breast cancer to endocrine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Fluorescent cytochemical detection of estrogen and progesterone receptors in breast fine-needle aspirates

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Immunocytochemical assay for estrogen receptor in patients with breast cancer: relationship to a biochemical assay and to outcome of therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Megestrol acetate in breast cancer--a panel discussion

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Variation of estrogen and progesterone receptor status in breast cancer after tamoxifen therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Progesterone in uterus and plasma. V. An assay of the progesterone cytosol receptor of the guinea pig uterus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Human breast tumor estrogen receptor: effects of molybdate and electrophoretic analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Use of an enzymeimmunoassay (EIA) for quantitation of cytosolic and nuclear estrogen receptor, and correlation with progesterone receptor in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Aggressive adriamycin-containing regimen (PM-FAC) in estrogen receptor-negative disseminated breast cancer. Results of a Southwest Oncology Group trial

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Induction of progesterone receptor with tamoxifen in human breast cancer with special reference to its behavior over time

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Influence of tamoxifen-medroxyprogesterone sequential therapy on estrogen and progesterone receptor contents of breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Inability of medroxyprogesterone acetate to down regulate estrogen receptor level in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

The relationship between family history, exposure to exogenous hormones, and estrogen receptor protein in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Mechanism of action of adjuvant chemotherapy in early breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Rapid analysis of estrogen and progesterone receptors using gel-exclusion high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Effect of ionic strength on charcoal adsorption assays of receptor-estradiol complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

An Improved Histochemical Method for Detection of Estrogen Receptors in Mammary Cancer: Comparison with Biochemical Assay

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Oestrogen receptor assay--limitation of the method

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Estrogen receptor immunocytochemistry for preoperative determination of estrogen receptor status on fine-needle aspirates of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Estrogen receptor protein in lesions of the male breast.A preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Estrogen receptor protein (ERP) in multiple tumor specimens from individual patients with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Blood groups and response to therapy for mammary cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Randomized trial of adjuvant tamoxifen combined with postoperative radiation therapy or adjuvant chemotherapy in postmenopausal breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

DNA binding ability of estrogen receptor from human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Survival with breast cancer: the importance of estrogen receptor quantity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

The clinical value of multiple steroid receptor assays in breast cancer management

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Quality control in steroid hormone receptor assays

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Estrogen and progestogen binders in human and rat mammary carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

A receptor molecule for estrogens: isolation from the rat uterus and preliminary characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Predictive value of tumor estrogen and progesterone receptor levels in postmenopausal women with advanced breast cancer treated with toremifene

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Recombinant human interferon alpha increases oestrogen receptor expression in human breast cancer cells (ZR-75-1) and sensitizes them to the anti-proliferative effects of tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

Estrogen and progesterone receptor content in human thyroid disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2423%2808%2960196-1

7 January 2021

10.1016/S0065-2423(08)60196-1

Identifiers

DOI

0 references

1 reference